| Validation of the Arabic version of the “self-evaluation of negative symptoms” scale (SNS) A Hajj, S Hallit, K Chamoun, H Sacre, S Obeid, C Haddad, S Dollfus, ... BMC psychiatry 20, 1-8, 2020 | 18 | 2020 |
| Mechanisms of neurorespiratory toxicity induced by fentanyl analogs—lessons from animal studies K Chamoun, L Chevillard, A Hajj, J Callebert, B Mégarbane Pharmaceuticals 16 (3), 382, 2023 | 6 | 2023 |
| Negative symptoms in schizophrenia: correlation with clinical and genetic factors A Hajj, S Hallit, K Chamoun, H Sacre, S Obeid, C Haddad, S Dollfus, ... Pharmacogenomics 22 (7), 389-399, 2021 | 4 | 2021 |
| Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders K Chamoun, J Mouawad, P Salameh, H Sacre, R Haddad, LR Khabbaz, ... BMC psychiatry 23 (1), 797, 2023 | 2 | 2023 |
| Alcohol and Sedative Use Disorders in the Lebanese Population: Role of Sleep and Psychiatric Factors K Chamoun, N Wehbe, P Salameh, H Sacre, M Atallah, J Mouawad, ... European Psychiatry 67 (S1), S131-S132, 2024 | | 2024 |
| Investigating Sex Differences in Opioid Use Disorder Risk Factors: Insights from Cross-Section Lebanese Study Population K Chamoun, P Salameh, H Sacre, J Mouawad, L Rabbaa, B Megarbane, ... European Psychiatry 67 (S1), S115-S115, 2024 | | 2024 |
| Opioid Use Disorder in Three Samples of the Lebanese Population: Correlation with Clinical and Genetic Factors K Chamoun, FHM Lteif, P Salameh, H Sacre, R Haddad, L Rabbaa, ... European Psychiatry 67 (S1), S99-S99, 2024 | | 2024 |
